TRVI

TREVI THERAPEUTICS INC

TRVI·89532M101·US·Common Stock·Healthcare - Biotechnology-Activist

TRVI (TREVI THERAPEUTICS INC) is held by 107 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($122.2M), FMR LLC ($95.9M), WELLINGTON MANAGEMENT GROUP LLP ($61.9M). Net institutional sentiment: Mixed.

107
Holders
Avg rating(20 Elite)
$794.9M
Total Value
58% (114)
Fund Consensus
60 buying - 44 selling
TRVISmart Money Verdict
View all
Held by 107 funds
20 elite
Who's Trading
ActivistNENew Enterprise Associates 16, L.P.10.5%May 7, 2026
ActivistFMR LLCFMR LLC6.3%May 6, 2026
ActivistThe Vanguard GroupThe Vanguard Group0.0%Mar 27, 2026
ActivistRURubric Capital Management LP2.9%Feb 13, 2026
ActivistVIKING GLOBAL INVESTORS LPVIKING GLOBAL INVESTORS LP4.2%Nov 14, 2025
ActivistFLFrazier Life Sciences Public Fund, L.P.7.0%Nov 14, 2025
ActivistBlackRock, Inc.BlackRock, Inc.5.6%Oct 17, 2025
InsiderSTSCIASCIA THOMASSell $17KMar 25, 2025
InsiderGLGOOD JENNIFER LSell $35KMar 21, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
10.2M(+1.1%)$122.2M0.0%+200.65%
30
Increased
8M(+23.7%)$95.9M0.0%+64.16%
36
Increased
5.2M(+52.4%)$61.9M0.0%+76.56%
41
New
5M$59.4M0.0%+45.51%
41
Decreased
4M(-13.4%)$47.3M0.0%+132.63%
0
Unchanged
3.2M$38.2M0.1%+165.45%
0
Decreased
2.8M(-7.7%)$35.6M0.0%+217.41%
0
Increased
2.8M(+15.1%)$33.2M0.0%+185.80%
33
Increased
2.7M(+9.5%)$31.8M0.0%+206.81%
32
Increased
2M(+79.9%)$23.8M0.2%+43.56%
52
Increased
1.7M(+11.4%)$20.4M0.0%+42.66%
32
Decreased
1.7M(-4.5%)$20.1M0.0%+126.24%
0
Increased
1.2M(+16.2%)$14.6M0.0%+95.41%
32
Increased
1.2M(+11.2%)$14.5M0.0%+138.01%
31
Increased
1.2M(+686.0%)$14.3M0.0%+52.40%
45
Increased
1M(+0.1%)$11.9M0.0%+51.45%
28
New
968,588$11.6M0.0%+45.51%
39
Increased
840,572(+0.5%)$10M0.0%+133.65%
28
Increased
806,659(+5.9%)$9.6M0.0%+237.23%
29
New
773,620$9.2M0.0%+45.51%
38

Showing 1-20 of 114

1 / 6

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used